Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
about
Rodent models of diabetic nephropathy: their utility and limitationsTelmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease.Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade.SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic miceEffects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.Regression of Renal Disease by Angiotensin II Antagonism Is Caused by Regeneration of Kidney VasculatureAlternative Interventions to Prevent Oxidative Damage following Ischemia/ReperfusionPrevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.The signaling pathway of NADPH oxidase and its role in glomerular diseases.Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
P2860
Q28073885-A3525EC0-2868-41B7-8221-3EBA31F6CC8BQ33618861-A104262F-E13B-4BA3-BC41-50341CC53E1AQ33645497-598DABD9-778C-418B-9CF0-4DC4FA1D1F57Q35050508-22AE4D21-AD00-492C-B788-2AF5318139C4Q35180432-66C8529D-F0F0-4033-9C4E-69811CDE0F94Q36112982-0A32ADA4-4A24-4F3C-B78C-6B390FB0F256Q36275012-CBCB3D68-9F17-4EB5-AA3D-4F9C324F997EQ36439575-9262920F-ED3E-4B44-BE61-D3C732B06A29Q36624639-59495D50-89D6-43A3-9C5E-A583A6DCC369Q37578724-B903F5EE-CABE-493C-AB06-60864412887CQ38014435-0A1C45BF-BCE0-4A21-B37E-326382349C83Q38155196-59CA8F08-063E-4D7A-821A-242FE5FCC747Q48111922-A6866732-414F-48E6-8810-14757AA11F45
P2860
Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Modulation of renal superoxide ...... L/6-Ins2(Akita) diabetic mice.
@en
type
label
Modulation of renal superoxide ...... L/6-Ins2(Akita) diabetic mice.
@en
prefLabel
Modulation of renal superoxide ...... L/6-Ins2(Akita) diabetic mice.
@en
P2093
P2860
P356
P1476
Modulation of renal superoxide ...... L/6-Ins2(Akita) diabetic mice.
@en
P2093
Hiroki Fujita
Hiromi Fujishima
Keiko Takahashi
Koga Komatsu
Mihoko Hosoba
Takamune Takahashi
Takuma Narita
Takuya Sakamoto
Tsukasa Morii
Yuichiro Yamada
P2860
P2888
P304
P356
10.1038/HR.2011.176
P577
2011-11-10T00:00:00Z
P5875
P6179
1014470235